Calculate the potential market size opportunity in dollars for Biopure in the human market and in
the animal market.
2. What is your recommendation to Biopure on the central question facing the company: Should
the company postpone the introduction of Oxyglobin until after Hemopure has established itself
in the marketplace? Why or why not?
3. Is it possible to leverage the opportunity offered by Oxyglobin without jeopardizing the potential
of Hemopure? If so, how?
please refer to the reading material called Biopure Corporation, I cannot upload the pdf there.